Waters Corporation (WAT)

NYSE Health Care Life Sciences Tools & Services S&P 500
$457.60
+4.52 (+1.00%)
Close of Nov 06, 2026 · end-of-day data
Source: Waters Corporation's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 03, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$2.17B$2.31B$2.42B$2.41B$2.37B$2.79B$2.97B$2.96B$2.96B$3.17B
Cost of revenue$891.45M$947.07M$992.56M$1.01B$1.01B$1.16B$1.25B$1.20B$1.20B$1.29B
Gross profit$1.28B$1.36B$1.43B$1.40B$1.36B$1.63B$1.72B$1.76B$1.76B$1.88B
Research & development$125.19M$132.59M$143.40M$142.96M$140.78M$168.36M$176.19M$174.94M$183.03M$195.71M
Selling, general & admin$512.33M$544.36M$536.90M$534.79M$553.70M$626.97M$658.03M$736.01M$690.15M$830.37M
Operating income$625.04M$662.20M$739.77M$708.46M$645.49M$821.71M$873.39M$817.68M$826.35M$802.59M
Interest expense$44.91M$56.84M$48.64M$48.69M$49.07M$44.94M$48.80M$98.86M$89.68M$69.55M
Pre-tax income$600.11M$641.10M$682.15M$678.24M$610.91M$806.19M$837.85M$736.24M$754.87M$754.88M
Income tax$78.61M$620.79M$88.35M$86.04M$89.34M$113.35M$130.09M$94.01M$117.03M$112.25M
Net income$521.50M$20.31M$593.79M$592.20M$521.57M$692.84M$707.75M$642.23M$637.83M$642.63M
EBITDA$676.72M$723.65M$797.73M$762.30M$714.17M$893.27M$945.39M$902.30M$913.37M$890.73M
EPS (basic)$6.46$0.25$7.71$8.76$8.40$11.25$11.80$10.87$10.75$10.80
EPS (diluted)$6.41$0.25$7.65$8.69$8.36$11.17$11.73$10.84$10.71$10.76
Diluted shares81.42M80.60M77.62M68.17M62.41M62.03M60.33M59.27M59.55M59.71M
Gross margin58.9%59.0%59.0%58.0%57.4%58.5%58.0%59.6%59.4%59.3%
Operating margin28.8%28.7%30.6%29.4%27.3%29.5%29.4%27.7%27.9%25.4%
Net margin24.1%0.9%24.5%24.6%22.1%24.9%23.8%21.7%21.6%20.3%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$505.63M$642.32M$796.28M$335.71M$436.69M$501.23M$480.53M$395.08M$325.36M$588.00M
Short-term investments$2.31B$2.75B$938.94M$1.43M$6.45M$68.05M$862.00K$898.00K$934.00K—
Receivables$489.34M$533.83M$568.32M$587.73M$573.32M$612.65M$722.89M$702.17M$733.37M$829.00M
Inventory$262.68M$270.29M$291.57M$320.55M$304.28M$356.10M$455.71M$516.24M$477.26M$572.00M
Total current assets$3.64B$4.27B$2.66B$1.31B$1.40B$1.63B$1.76B$1.75B$1.67B$2.15B
Goodwill$352.08M$359.82M$355.61M$356.13M$444.36M$437.87M$430.33M$1.31B$1.30B$1.34B
Total assets$4.66B$5.32B$3.73B$2.56B$2.84B$3.09B$3.28B$4.63B$4.55B$5.08B
Total current liabilities$520.32M$606.16M$448.93M$591.33M$804.98M$680.51M$785.74M$789.58M$789.76M$1.24B
Short-term debt$125.30M$100.27M$178.00K$100.37M$150.00M$0————
Long-term debt$1.70B$1.90B$1.15B$1.58B$1.21B$1.51B$1.52B$2.31B$1.63B$947.00M
Total debt$1.83B$2.00B$1.15B$1.68B$1.36B$1.51B$1.52B$2.31B$1.63B$947.00M
Total liabilities$2.36B$3.09B$2.16B$2.77B$2.61B$2.73B$2.78B$3.48B$2.73B$2.52B
Shareholders' equity$2.30B$2.23B$1.57B-$216.28M$232.14M$367.55M$504.49M$1.15B$1.83B$2.56B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$642.92M$697.64M$604.45M$643.09M$790.51M$747.27M$611.66M$602.81M$762.12M$652.55M
Capital expenditures———————$160.63M$142.48M$112.75M
Free cash flow$642.92M$697.64M$604.45M$643.09M$790.51M$747.27M$611.66M$442.18M$619.64M$539.81M
Investing cash flow-$487.92M-$535.75M$1.68B$768.80M-$264.09M-$231.63M-$107.97M-$1.44B-$143.09M-$152.25M
Financing cash flow-$115.70M-$63.87M-$2.12B-$1.87B-$440.50M-$438.27M-$509.63M$754.95M-$696.67M-$237.21M
Share buybacks$325.76M$332.54M$1.32B$2.47B$196.41M$648.93M$626.06M$70.28M$13.54M$14.67M
Stock-based compensation$41.00M$39.44M$37.54M$38.58M$36.87M$29.92M$42.56M$36.87M$44.71M$54.13M
Depreciation & amortization$51.68M$61.45M$57.95M$53.84M$68.69M$71.56M$72.00M$84.62M$87.02M$88.14M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.